drugset / Trial / NCT02226926
Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Investigation of the mechanism of dipyridamole action in platelets in an in-vivo study with healthy volunteers treated Aggrenox in comparison with volunteers treated with Persantin Retard or Acetylsalicylic Acid using platelet Vasodilator-Stimulated-Phosphoprotein (VASP)-phosphorylation as indication for an action and measurements of dipyridamole plasma levels
Timeline
- Start
- 2000-07
- Primary completion
- 2000-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | — | — |
| Subject | Dipyridamole | Other / unclassified | — | — |
Indications
No indication recorded.